Concepedia

Author

Anne I.J. Arens

Radboud University NijmegenORCID

Also Known As

A Arens, A I J Arens, A. Arens, A. I. J. Arens, A.I. Arens, A.I.J. Arens, Anne Arens, Anne I. Arens, Anne I. J. Arens, Anne I.J. Arens

110

Publications

2.6K

Citations

22

H-Index

56

Concepts

All Affiliations

Radboud University NijmegenRadboud University Medical CenterNational Center for Tumor DiseasesHeidelberg UniversityGerman Cancer Research Center
AI

About

Anne I.J. Arens is an author at Radboud University Nijmegen specializing in medicine, health sciences, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

1.1K

2

Health Sciences

8

8

192

3

Engineering

4

4

244

4

Biomedical Engineering

1

1

186

5

Cell Biology

1

1

26

Anne I.J. Arens

×

31

Publications

2.3K

Citations

21

H-Index

YearCitations

An unbiased genome-wide analysis of zinc-finger nuclease specificity

Richard Gabriel, Angelo Lombardo, Anne I.J. Arens,

Nature Biotechnology

2011

517

Distinct Types of Tumor-Initiating Cells Form Human Colon Cancer Tumors and Metastases

Sebastian M. Dieter, Claudia R. Ball, Christopher M. Hoffmann,

Cell stem cell

2011

299

Comprehensive genomic access to vector integration in clinical gene therapy

Richard Gabriel, Ralph Eckenberg, Anna Paruzynski,

Nature Medicine

2009

186

Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing

Anna Paruzynski, Anne I.J. Arens, Richard Gabriel,

Nature Protocols

2010

176

Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk

Janka Mátrai, Alessio Cantore, Cynthia C. Bartholomae,

Hepatology

2011

135

High-resolution analysis of the human T-cell receptor repertoire

Eliana Ruggiero, Jan P. Nicolay, Raffaele Fronza,

Nature Communications

2015

116

Retroviral Gene Therapy for X-linked Chronic Granulomatous Disease: Results From Phase I/II Trial

Hyoung Jin Kang, Cynthia C. Bartholomae, Anna Paruzynski,

Molecular Therapy

2011

102

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study

Marie José Kersten, Julia Driessen, Josée M. Zijlstra,

Haematologica

2020

92

Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)

Pieternella J. Lugtenburg, Peter de Nully Brown, Bronno van der Holt,

Journal of Clinical Oncology

2020

82

Lentiviral Vector Integration Profiles Differ in Rodent Postmitotic Tissues

Cynthia C. Bartholomae, Anne I.J. Arens, Kamaljit S. Balaggan,

Molecular Therapy

2011

54

Page 1